CN104877869A - 一种提高人体免疫力的霍山石斛酒的制备方法 - Google Patents
一种提高人体免疫力的霍山石斛酒的制备方法 Download PDFInfo
- Publication number
- CN104877869A CN104877869A CN201510230242.4A CN201510230242A CN104877869A CN 104877869 A CN104877869 A CN 104877869A CN 201510230242 A CN201510230242 A CN 201510230242A CN 104877869 A CN104877869 A CN 104877869A
- Authority
- CN
- China
- Prior art keywords
- wine
- herba dendrobii
- preparation
- body immunity
- dendrobium huoshanense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 59
- 230000036039 immunity Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241001678082 Dendrobium huoshanense Species 0.000 title abstract 6
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 6
- 241000005787 Cistanche Species 0.000 claims abstract description 5
- 241000208688 Eucommia Species 0.000 claims abstract description 5
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 5
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 27
- 230000036541 health Effects 0.000 claims description 24
- 235000020097 white wine Nutrition 0.000 claims description 15
- 230000001737 promoting effect Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 240000001638 Scurrula parasitica Species 0.000 claims description 4
- 210000003056 antler Anatomy 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 210000001320 hippocampus Anatomy 0.000 claims description 4
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000007812 deficiency Effects 0.000 abstract description 9
- 206010024419 Libido decreased Diseases 0.000 abstract description 4
- 208000013507 chronic prostatitis Diseases 0.000 abstract description 4
- 201000007094 prostatitis Diseases 0.000 abstract description 4
- 206010013954 Dysphoria Diseases 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 2
- 206010016256 fatigue Diseases 0.000 abstract description 2
- 206010022437 insomnia Diseases 0.000 abstract description 2
- 230000003014 reinforcing effect Effects 0.000 abstract description 2
- 241000209020 Cornus Species 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 2
- 238000002156 mixing Methods 0.000 abstract 2
- 238000002791 soaking Methods 0.000 abstract 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 244000291564 Allium cepa Species 0.000 abstract 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241001247203 Syngnathidae Species 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 23
- 235000009508 confectionery Nutrition 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000013642 negative control Substances 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 241000411851 herbal medicine Species 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 102000014150 Interferons Human genes 0.000 description 6
- 108010050904 Interferons Proteins 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229940079322 interferon Drugs 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 208000017667 Chronic Disease Diseases 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000003442 weekly effect Effects 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000012201 sexual and gender identity disease Diseases 0.000 description 3
- 208000015891 sexual disease Diseases 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000935235 Fritillaria meleagris Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 208000004224 Opium Dependence Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- -1 anti-stress Substances 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 150000001886 cortisols Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000020880 diabetic diet Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种提高人体免疫力的霍山石斛保健酒的制备方法,以白酒为基酒和中药材调配而成,所述的中药材包括霍山石斛、肉苁蓉、西洋参、淫羊藿、枸杞子、熟地黄、山萸肉、杜仲、桑寄生、泽泻、肉桂、韭菜子、海马、鹿茸、甘草等15味中药;其制备方法是将上述药材粉碎成80-120目细粉,加入5-8倍量55-60°白酒,混合浸泡8-12天,滤出酒液;再加入3-5倍量55-60°白酒,继续浸泡6-9天,滤出酒液,合并两次酒液,调配至合适酒度,即得;本发明的霍山石斛酒具有补肾壮阳、益气生精、强身健体的功效,对肾阳不足、气虚血弱引起的性欲低下、精冷无力、腰腿酸软、虚烦失眠、慢性前列腺炎等具有很好的疗效。
Description
技术领域
本发明涉及一种药膳,特别是一种提高人体免疫力的保健药酒,具体为一种霍山石斛酒的制备方法。
背景技术
中医学认为药食同源,饮食与健康两者密切相关。所以中医养生学千年不衰,尤其是在科学技术迅猛发展的今天,西药滥用所产生的人体对细菌病毒的抗药性不但无法控制病情,而且药物的残留也严重污染环境,危害着人体的健康,所以当今人们都呼唤回归大自然,盼望无残留的绿色食品,医药工作者都试图从天然动植物中寻找能增强人体免疫力的动物与中草药调节剂以防治这些常见和多发性疾病。民以食为天,食疗与食养是中医养生学的重要部分,所谓“三分疾病七分养”,“药补不如食补”,明确道出了药膳的重要性。中国是中草药的故乡和药膳食疗的发源地,不乏抗病菌、病毒的中草药和养生、提高人体免疫力的药膳。各地都在应用药膳食疗养生防治病疾病中巳积累了许多宝贵的经验,本公司研发的《霍山石斛酒》就是一种采用中草药药酒食疗提高人体免疫力的具体范例。
健康是和谐人生的基石,身体是美好生活的本钱;现代社会由于生活节奏快,特别是男性长期感受工作和生活的巨大压力,导致精神处于高度紧张之中,很多人都或多或少地出现了亚健康状态,以致男性出现性生活时间变短,女性出现性冷淡,给本人及家庭带来一定程度的伤害。
处于亚健康状态的性功能障碍涉及到内分泌或神经系统紊乱,但有别于器质性性功能损伤,通常表现为性欲低下、勃起困难、无性高潮,严重的会导致精冷、不育现象,从而影响家庭和谐与安稳。从中医角度分析产生上述症状的原因主要表现为肾阳不足、机能减退、阴虚精滑,西医多采用激素类药物,普遍存在治标不治本现象,停药后易复发。随着人们生活水平的提高,对健康问题越来越重视,从传统中药中发掘无毒的温肾补阳、强身健体、延缓衰老类药物,已成为研究的热点。
酒是一种良好的溶媒,现代科学实验表明中药材中的大部分有效成分均能溶于其中,同时酒还有防腐作用,可防止有效成分的腐败,提高药效的稳定性。将强身健体的中药与酒"溶"于一体的药酒,其中溶解了中药材的各种有效成分,药借酒力、酒助药势而充分发挥其功效;通过白酒的浸泡能析出霍山石斛等中药材的有效成分,从而达到温补肾阳,滋阴养血、延年养颜的效果。
发明内容
本发明的目的是根据中医学的基础理论和辨证施治原则,研制一种既能提高人体机体免疫力,又能促进虚弱机体康复、兼治一些阴阳失调的慢性疾病的中药药酒,本发明乃一种用于食疗的药酒,采用名贵中草药霍山石斛、肉苁蓉、西洋参、淫羊藿、枸杞子、熟地黄、山萸肉、杜仲、桑寄生、泽泻、白芍、韭菜子、海马、鹿茸和甘草等进行组合,经特殊工艺加工而成,具有保肝健脾、滋阴壮阳、补血益气、生津润燥功能,这些药物组合使各药物功效产生协同作用,从而能够有效地产生抗体和免疫力,促进机体康复、兼治一些阴阳失调的慢性疾病。药酒处方中以名贵中草药霍山石斛为主,霍山石斛,又称米斛,是石斛中的极品,性微寒,味甘、淡,清热生津、滋养肝肺、开胃健脾,益精强阴、生津止渴、补虚赢、除胃中虚火;大补阴虚,对于虚劳失血、咯血、肠风血痔、盗汗夏季热、热性病和结核病后期及恢复期具有很好的滋阴清热、强肝滋肺补肾作用,对高热病症、脏腑劳损及病后虚弱有显著的疗效和修复作用;肉苁蓉,甘、咸,温,归肾、大肠经。补肾阳,益精血,润肠通便。用于阳痿,不孕,腰膝酸软,筋骨无力,肠燥便秘;西洋参,甘、微苦,凉。归心、肺、肾经。补气养阴,清热生津。用于气虚阴亏,内热,咳喘痰血,虚热烦倦,消渴,口燥咽干,有抗疲劳、抗氧化、抗应激、抑制血小板聚集、降低血液凝固性的作用;淫羊藿,辛、甘,温,归肝、肾经。补肾阳,强筋骨,祛风湿。用于阳痿遗精,筋骨痿软,风湿痹痛,麻木拘挛;枸杞子,甘,平,归肝、肾经。滋补肝肾,益精明目,虚劳精亏,腰膝酸痛,眩晕耳鸣,阳萎遗精,内热消渴,是当今中药材中养颜美容、提高免疫力的常用药;熟地黄,味甘,性温,归肝、肾经。补血滋润;益精填髓;山萸肉,酸、涩,微温,归肝、肾经。补益肝肾,涩精固脱;杜仲,甘,温。归肝、肾经,补肝肾、壮腰膝、强筋骨;桑寄生,苦、甘,平,归肝、肾经。补肝肾,强筋骨,祛风湿;泽泻,味甘、淡;性寒,归肾、膀胱经,利水渗湿;泄热通淋;肉桂,性大热,味辛、甘,归肾、脾、心、肝经,补火助阳,引火归源,散寒止痛,活血通经;韭菜子,性辛,甘,温,归肾、肝经,温补肝肾,壮阳固精,暖腰膝;海马,甘,温,归肝、肾经。强身健体、补肾壮阳、舒筋活络、消炎止痛、镇静安神;鹿茸,甘、咸,温,归肾、肝经,壮肾阳,益精血,强筋骨;甘草,味甘、性平,归心、肺、脾、胃经,补脾益气,清热解毒、祛痰止咳。上述名贵诸药与白酒合用,能有机地配合,共奏清热泻火、凉血解毒、抗菌消炎、提高机体免疫力,以达到防疫灭病,康复之功。本药酒制剂处方配合严谨,不存在十八反、十九畏的配伍禁忌,实验也证明本处方为安全无毒制剂,味甘甜,无苦涩,十分适合消费者的口味。各种药材所占重量百分比如下:霍山石斛11%、肉苁蓉11%、西洋参16%、淫羊藿7%、枸杞子16%、熟地黄14%、山萸肉7%、杜仲3%、桑寄生13%、泽泻3%、白芍2%、韭菜子2%、海马1%、鹿茸1%和甘草2%。(上限及下限的临界值)。
制作工艺和方法
《霍山石斛酒》的制备方法如下:
1.将霍山石斛等15味中草药洗净,切成小段后干燥,粉碎成120目的粉末。
2.将上述药材粉末装入酒坛,加入8倍量的60°白酒,每隔24小时搅拌1次,浸泡12天后,滤出酒液。再加入5倍量60°白酒,每隔24小时搅拌1次,继续浸泡9天滤出酒液。
3.按重量比为1:8,加入蜂蜜,以无菌蒸馏水将酒液调配成48°保健酒。
4、服用方法:每天两次,分中午和晚上各一次;每次50毫升(肝炎患者减半),中午在饭前半小时服下;晚上一次在睡觉前一小时喝下,大约在20-21点喝最好。
本药酒发明的原理是采用名贵中草药泡酒,诱导人体产生干扰素、调动机体全身免疫系统,抵抗热性和慢性疾病;这些能诱导动物体产生干扰素、调人体全身免疫系统的中草药制剂不但具有抗病作用,而且无副作用,对人体无害。干扰素在机体内对病毒及病原微生物有突出效果,诱生干扰素中草药防治疾病是通过细胞因子网络、T细胞网络、免疫细胞网络、机体水平分泌-免疫网络的调节,增强了机体免疫力,从根本上达到杀灭和控制病毒及病原微生物的作用。从实验和临床结果来看,诱生干扰素的中草药具有广谱、高效、无毒性、作用时间长、价格便宜、易操作等特点,因此诱生干扰素中草药对防治人体疾病,滋阴壮阳,强身健体、益精养血、延年养颜,尤其是热性病和慢性病,有着独特的优势和广阔的前景。
本发明的优点:本发明霍山石斛保健酒酒色橙黄透明,药香浓郁、柔和甘醇,长期饮用有调和阴阳、滋补气血、延年养颜有很好的效果,同时,霍山石斛保健酒具有温补肾阳、益气生精、延缓衰老、增强免疫等功效,对肾阳不足、气虚血弱引起的性欲低下、精冷无力、腰腿酸软、虚烦失眠等具有很好的疗效。
具体实施方式
以下通过试验例来进一步阐述本药膳对人体疾病,尤其是热性病、糖尿病和慢性病的防治效果。
实验例1:慢性乙肝患者伴随病毒膜增殖性肾炎,采用《霍山石斛酒》每周14次,配合药物巩固治疗,据观察和对比,采用药物配合本《霍山石斛酒》的病例共20例,2个月为一疗程,食疗2-3个疗程,20例中,显效者(症状消失,尿常规正常)12例,有效者6例,无效者2例,总有效率达90%,随访2年,疗效稳定;故可判定《霍山石斛酒》对慢性乙肝患者伴随病毒膜增殖性肾炎有很好的疗效。
实验例2:气虚阳痿或性功能低下,采用本《霍山石斛酒》每周14-20次,2个月为一疗程,食疗期间停用他法。嘱咐患者禁烟,严禁喝其他白酒,禁手淫,忌房事及精神紧张,清心寡欲,作息有度,适当运动,清除心理因素对本病的影响。食疗结果,《霍山石斛酒》对气虚阳痿或性功能低下患者86例,其中疗效显著者53例,好转者18例,无效者15例,总有效率达到82%,有效病例中,服用时间最短者28天,最长者56天,用药膳治疗气虚阳痿或性功能低下,具有服用方便,口感好,无任何毒副作用,患者乐于接受。
实验例3:慢性糖尿病,采用本药膳每周7次,每次在晚上睡觉前一小时(20-21点)服下50毫升,2个月为一疗程,配合正常量的胰岛素给药、严格控制血糖和糖尿病饮食;食疗结果:《霍山石斛酒》对糖尿病性患者26例,用1个疗程后,其中疗效显著者23例,血糖值平均由12.27mmol/L(221mg)降低至10.43mmol/L(188mg),好转者2例,无效者1例,总有效率达到96%。与那些只采用正常量的胰岛素给药、没有用《霍山石斛酒》的糖尿病患者药的对照组相比,差异非常显著。
实验例4:慢性前列腺炎,采用本药膳每周14-20次,每次50毫升,2个月为一疗程,配合常用量的利尿消炎药、严格控制憋尿,食疗结果,《霍山石斛酒》对慢性前列腺炎患者160例,用1个疗程后,其中疗效显著者130例,占82%,好转者24例,无效者6例,总有效率达到96%。大部分患者在用药膳后的第二周晚上起床拉尿次数减少,并能逐渐恢复性欲和体力,治疗慢性前列腺炎疗效十分显著。
实验例5:肺结核,采用本药膳每周14次,2个月为一疗程,配合鱼腥草、夏枯草、川贝、天冬等中药煎剂治疗肺结核,食疗结果,《霍山石斛酒》对肺结核患者42例,用1个疗程后,其中疗效显著者32例,占76%,好转者6例,无效者4例,总有效率达到90%,大部分患者在用药膳后半个月,发热、盗汗、咳嗽、气喘、咳血、食欲缺乏等症状能有不同程度的好转,逐渐康复,疗效十分显著。
动物试验具体实施方式
为便于对本发明的理解,下面提供霍山石斛保健酒对小鼠生殖能力和抗疲劳试验资料,进一步阐述本发明的技术特点:
试验例1霍山石斛保健酒对小鼠生殖能力的影响
试验设4个组,每组10只,体质量为18-22g,分别为阴性对照组、高低剂量各1组及模型组。以氢化可的松进行肾阳虚证造模,除阴性对照组外,其余小鼠每日肌注氢化可的松25mg/kg,连续注射12天,以畏寒喜暖、四肢发凉、小便清稀、消瘦为造模是否成功指标;造模成功后开始连续灌胃30天,每天以0.25ml/10g BW的剂量灌胃给药,高、低剂量组分别为48°和38°霍山石斛保健酒。模型组和阴性对照组每次给予同等容量的蒸馏水灌胃。
表1 受试药物对小鼠睾丸重量、睾丸酮及促黄体生产激素的影响
注:与模型组相比,*P<0.01。
由表1可知,模型组小鼠睾丸重量、睾丸酮及促黄体生产激素与阴性对照组相比明显下降,而睾丸酮和促黄体生产激素与小鼠的生殖机能密切相关。霍山石斛保健酒能使氢化可的松产生的影响得到显著的缓解。统计学分析表明,阴性对照组、高低剂量组与模型组相比有显著性差异(P<0.01),而阴性对照组和高低剂量组之间无显著性变化(P>0.05)。
试验例2受试物对小鼠负重游泳试验、运动后血清尿素和肝糖原测定结果
试验设4个组,每组10只,体质量为18-22g,分别为阴性对照组、高低剂量各1组及白酒组。连续灌胃30天,每天以0.25ml/10g BW的剂量灌胃给药,高、低剂量组分别为48°和38°霍山石斛保健酒。白酒组灌胃同等剂量的白酒。阴性对照组每次给予同等容量的蒸馏水。
负重游泳实验在末次给药1小时后,在小鼠尾根经细线拴住1g的铅块,于游泳箱中游泳,水深为30cm,温度为25士1°,小鼠自开始游泳至死亡时间为负重游泳时间。
血清尿素实验在末次给药后1小时后,在30°水温水中游泳100min,取出游泳箱休息1小时后摘眼球取血,采用酶法试剂盒测定。
肝糖原实验在末次给药1小时后,处死小鼠,取肝脏,精密称取50mg,采用蒽酮法测定肝糖原值。
表2受试药物对小鼠负重游泳、运动后血清尿素和肝糖原的影响
注:与白酒组和阴性对照组相比,*P<0.01。
由表2可知,灌胃霍山石斛药酒组小鼠的负重游泳时间与阴性对照和白酒组相比,有显著性差异(P<0.01)。运动后血清尿素值显示,霍山石斛药酒组与阴性对照和白酒组明显降低(P<0.01)。但在肝糖原储备中,各组没有显著性变化(P>0.05)。说明本发明的霍山石斛保健酒具有增强体质,抗疲劳的功效。
Claims (6)
1.一种提高人体免疫力的霍山石斛酒的制备方法,其特征在于:以纯粮酿造的白酒为基酒的泡制酒,对霍山石斛等多种中药材进行浸泡制得;制得霍山石斛酒。
2.根据权利要求1所述的提高人体免疫力的霍山石斛酒的制备方法,其特征在于:所述的中药材配方为霍山石斛30g、肉苁蓉30g、西洋参45g、淫羊藿20g、枸杞子45g、熟地黄40g、山萸肉20g、杜仲10g、桑寄生10g、泽泻10g、白芍5g、韭菜子5g、海马5g、鹿茸3g和甘草5g。
3.根据权利要求1所述的提高人体免疫力的霍山石斛酒的制备方法,其特征在于:所述的白酒酒精度为55-60°。
4.根据权利要求2所述的提高人体免疫力的霍山石斛酒的制备方法,其特征在于:所述的中药材粉碎成80-120目药粉。
5.根据权利要求1所述的提高人体免疫力的霍山石斛酒的制备方法,其特征在于具体包括以下内容:首次加入5-8倍量55-60°白酒,与药粉充分混匀浸泡8-12天,滤出酒液,密封储存备用;再加入3-5倍量55-60°白酒,继续浸泡6-9天,滤出酒液,合并两次酒液,最后按重量比为1:8,加入蜂蜜,以无菌蒸馏水将酒液调配成保健酒。
6.根据权利要求5所述的提高人体免疫力的霍山石斛酒的制备方法,其特征在于:将酒液调配成38-48°系列保健酒。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510230242.4A CN104877869A (zh) | 2015-05-07 | 2015-05-07 | 一种提高人体免疫力的霍山石斛酒的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510230242.4A CN104877869A (zh) | 2015-05-07 | 2015-05-07 | 一种提高人体免疫力的霍山石斛酒的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104877869A true CN104877869A (zh) | 2015-09-02 |
Family
ID=53945550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510230242.4A Pending CN104877869A (zh) | 2015-05-07 | 2015-05-07 | 一种提高人体免疫力的霍山石斛酒的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104877869A (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105524806A (zh) * | 2016-01-19 | 2016-04-27 | 霍山延年居石斛科技有限公司 | 一种增强体质的石斛酒 |
| CN105543054A (zh) * | 2016-02-24 | 2016-05-04 | 齐芳 | 一种米斛保健酒及其制作方法 |
| CN106520484A (zh) * | 2016-12-27 | 2017-03-22 | 广东国方医药科技有限公司 | 一种补肾壮阳铁皮石斛酒及其制备方法 |
| CN111575142A (zh) * | 2020-07-09 | 2020-08-25 | 安徽神农泽中医药科技发展有限公司 | 一种提高滋阴补虚的功能性石斛酒制备方法 |
| CN111700974A (zh) * | 2020-08-07 | 2020-09-25 | 黄泽先 | 一种石斛滋阴降糖丸及其制备方法 |
| CN111743974A (zh) * | 2020-07-20 | 2020-10-09 | 安徽神禾堂中药保健品开发有限公司 | 提高人体免疫力的霍山石斛中药组合物及其制备方法 |
| CN111759951A (zh) * | 2020-07-13 | 2020-10-13 | 安徽神农泽中医药科技发展有限公司 | 一种疏通人体性腺通道的功能性石斛咖啡的制备方法及应用 |
| CN115317569A (zh) * | 2022-09-21 | 2022-11-11 | 安徽神禾堂中药保健品开发有限公司 | 一种石斛滋阴补气降糖丸及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102559457A (zh) * | 2012-01-16 | 2012-07-11 | 澄思源生物科技(上海)有限公司 | 一种铁皮石斛酒及其泡制方法 |
| CN104277953A (zh) * | 2013-07-04 | 2015-01-14 | 张征 | 一种铁皮石斛酒的配制工艺 |
-
2015
- 2015-05-07 CN CN201510230242.4A patent/CN104877869A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102559457A (zh) * | 2012-01-16 | 2012-07-11 | 澄思源生物科技(上海)有限公司 | 一种铁皮石斛酒及其泡制方法 |
| CN104277953A (zh) * | 2013-07-04 | 2015-01-14 | 张征 | 一种铁皮石斛酒的配制工艺 |
Non-Patent Citations (1)
| Title |
|---|
| 艾铁民等主编: "《中国药用植物志 第12卷》", 31 January 2013, 北京大学医学出版社 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105524806A (zh) * | 2016-01-19 | 2016-04-27 | 霍山延年居石斛科技有限公司 | 一种增强体质的石斛酒 |
| CN105543054A (zh) * | 2016-02-24 | 2016-05-04 | 齐芳 | 一种米斛保健酒及其制作方法 |
| CN106520484A (zh) * | 2016-12-27 | 2017-03-22 | 广东国方医药科技有限公司 | 一种补肾壮阳铁皮石斛酒及其制备方法 |
| CN111575142A (zh) * | 2020-07-09 | 2020-08-25 | 安徽神农泽中医药科技发展有限公司 | 一种提高滋阴补虚的功能性石斛酒制备方法 |
| CN111759951A (zh) * | 2020-07-13 | 2020-10-13 | 安徽神农泽中医药科技发展有限公司 | 一种疏通人体性腺通道的功能性石斛咖啡的制备方法及应用 |
| CN111743974A (zh) * | 2020-07-20 | 2020-10-09 | 安徽神禾堂中药保健品开发有限公司 | 提高人体免疫力的霍山石斛中药组合物及其制备方法 |
| CN111700974A (zh) * | 2020-08-07 | 2020-09-25 | 黄泽先 | 一种石斛滋阴降糖丸及其制备方法 |
| CN115317569A (zh) * | 2022-09-21 | 2022-11-11 | 安徽神禾堂中药保健品开发有限公司 | 一种石斛滋阴补气降糖丸及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104877869A (zh) | 一种提高人体免疫力的霍山石斛酒的制备方法 | |
| CN105296309A (zh) | 一种补肾壮阳中药养生保健酒 | |
| CN104195018B (zh) | 一种补肾壮阳的保健酒 | |
| CN101129878A (zh) | 一种治疗子宫脱垂的中药制剂 | |
| CN105770835A (zh) | 一种治疗风湿骨病益肾壮阳的药酒及其制备方法 | |
| CN102807943A (zh) | 一种补肾乌发养颜的保健药酒 | |
| CN105194316A (zh) | 一种补肾壮阳增强免疫力的药酒 | |
| CN102772569A (zh) | 一种保健药酒 | |
| CN1132616C (zh) | 一种治疗痹证病的中药 | |
| CN104069265A (zh) | 一种治疗阳痿的中药酒及其制备方法 | |
| CN112603987B (zh) | 一种治疗男性勃起障碍的贴剂及其制备方法 | |
| CN104042774A (zh) | 一种治疗骨质疏松症的药物组合物 | |
| CN102512647A (zh) | 一种治疗虚寒性腹痛的中药组合物 | |
| CN104524235A (zh) | 一种治疗心脏神经症中药组合物 | |
| CN105031235A (zh) | 一种灵芝山茱萸养生酒及其制作方法 | |
| CN104997956A (zh) | 贝赛特氏综合症及其治疗药物 | |
| CN111575142A (zh) | 一种提高滋阴补虚的功能性石斛酒制备方法 | |
| CN104491324A (zh) | 一种患者术后用活血通络气雾剂 | |
| CN104606469A (zh) | 一种治疗失眠的中药组合物 | |
| CN104147277A (zh) | 一种治疗重症肌无力的中药制剂及制备方法 | |
| CN102872420A (zh) | 一种治疗风湿性关节炎的药物及其制备方法 | |
| CN107737259A (zh) | 一种提高男性性功能的中药组方 | |
| CN105796860A (zh) | 速效接骨彝药 | |
| CN104758539A (zh) | 一种治疗乏力的中药组合物 | |
| CN105688038A (zh) | 一种破伤风合剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150902 |